Holders — by stockHoldings — by fund
venBio Partners LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001776382
$519.4M
disclosed book value
7
positions
30.9%
largest position share
Positions, as of 2026-06-30
top 7 of 7 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | PHARVARIS N V | 4.6M | $160.6M | 30.9% |
| 2 | PBLSPARABILIS MEDICINES INC | 5.3M | $144.1M | 27.8% |
| 3 | ALMSALUMIS INC | 4.5M | $127.4M | 24.5% |
| 4 | ACHVACHIEVE LIFE SCIENCE INC | 5.9M | $38.6M | 7.4% |
| 5 | ALXOALX ONCOLOGY HLDGS INC | 12.9M | $26.7M | 5.1% |
| 6 | HRMYHARMONY BIOSCIENCES HLDGS IN | 472,194 | $17.2M | 3.3% |
| 7 | LYELLYELL IMMUNOPHARMA INC | 337,697 | $4.7M | 0.9% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.